Anti-tumor effects of Rubratoxin B on cell toxicity, inhibition of cell proliferation, cytotoxic activity and matrix metalloproteinase-2,9

Toxicology in Vitro

Volumn 21, Issue 4, 2007, Pages 646-650

  Wang, Tao ^a   Zhang, Yi ^a   Wang, Yi ^b   Pei, Yue hu ^c  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anti tumor; Cell cycle inhibitor; Cytotoxic activity; Penicillium purpurogenum; Pyricularia oryzae; Rubratoxin B

Indexed keywords

GELATINASE A; GELATINASE B; RUBRATOXIN B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOASSAY; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; ENZYME INHIBITION; FERMENTATION; FLOW CYTOMETRY; FUNGAL STRAIN; HUMAN; HUMAN CELL; METABOLITE; MORPHOLOGY; MYCELIUM; PENICILLIUM PURPUROGENUM; PYRICULARIA ORYZAE; SOIL ANALYSIS;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYCELIUM; MYCOTOXINS; PENICILLIUM; SOIL MICROBIOLOGY; TETRAZOLIUM SALTS; THIAZOLES;

FUNGI; MAGNAPORTHE GRISEA; PENICILLIUM PURPUROGENUM;

EID: 34047257543     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.01.001     Document Type: Article

References (16)

1. Albright C.F., Graciani N., Han W., Yue E., Stein R., Lai Z., Diamond M., Dowling R., Grimminger L., Zhang S.Y., Behrens D., Musselman A., Bruckner R., Zhang M., Jiang X., Hu D., Higley A., Dimeo S., Rafalski M., Mandlekar S., Car B., Yeleswaram S., Stern A., Copeland R.A., Combs A., Seitz S.P., Trainor G.L., Taub R., Huang P., and Oliff A. Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity. Molecular Cancer Therapeutics 4 (2005) 751-760
2. Benjamin I.J. Matrix metalloproteinases: from biology to therapeutic strategies in cardiovascular disease. Journal of Investigative Medicine 49 (2001) 381-397
3. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica et Biophysica Acta 1477 (2000) 267-283
4. Engelhardt J.A., Carlton W.W., Rebar A.H., and Hayes A.W. Rubratoxin B mycotoxicosis in the Swiss ICR mouse. Food and Chemical Toxicology 26 (1988) 459-466
5. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circulation Research 90 (2002) 251-262
6. Giannelli G., Bergamini C., Marinosci F., Fransvea E., Quaranta M., Lupo L., Schiraldi O., and Antonaci S. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. International Journal of Cancer 97 (2002) 425-431
7. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. European Journal of Cell Biology 74 (1997) 111-122
8. Ii M., Yamamoto H., Adachi Y., Maruyama Y., and Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Experimental Biology and Medicine 231 (2006) 20-27
9. Kobayashi H., Namikoshi M., Yoshimoto T., and Yokochi T. A screening method for antimitotic and antifungal substances using conidia of P. oryzae, modification and application to tropical marine fungi. Journal of Antibiotics 49 (1996) 873-879
10. Lokeshwar B.L., Selzer M.G., Zhu B.Q., Block N.L., and Golub L.M. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. International Journal of Cancer 98 (2002) 297-309
11. Luttun A., Dewerchin M., Collen D., and Carmeliet P. The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies. Current Atherosclerosis Reports 2 (2000) 407-416
12. Mannello F., and Gazzanelli G. Tissue inhibitors of metalloproteinases and programmed cell death: conundrums controversies and potential implications. Apoptosis 6 (2001) 479-482
13. Nagase H., and Woessner J.F. Matrix metalloproteinases. The Journal of Biological Chemistry 31 (1999) 21491-21494
14. Sakamoto K., Izumi S., Miyauchi M., and Okuhara M. A new assay method for immunosuppressants with a tacrolimus (FK506)-like mode of action. Journal of Antibiotics 48 (1995) 727-729
15. 13C NMR - spektroskopie der nonadride. Helvetica Chimica Acta 64 (1981) 2791-2801
16. Wilson B.J., and Harbison R.D. Rubratoxins. American Journal of Veterinary Medicine 163 (1973) 1274-1277